• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct27
Anteon Biotech Displays ATG-201 Preclinical Data and Plans to Advance to Clinical Development
01:00
Sep16
ATHEX repurchased 29,500 shares for HKD 197,700
11:44
Sep10
Ataichan Biopharma repurchased 146,000 shares
10:51
Sep3
Atreca Receives Breakthrough Therapy Designation and Plans to Repurchase Shares
05:40
Sep1
Deer MediTech Plans to Repurchase up to 40 Million HKD in Shares
04:28
Aug27
Dat Biopharma's ATG022 Receives Breakthrough Therapy Designation in China and Unveils Latest Data
01:21

Schedules & Filings

Schedules
Filings
Aug22
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 29.1 M, Net Income -41.8 M, EPS -0.0673

Mar21
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 16.58 M, Net Income -80.97 M, EPS -0.1301

Aug23
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 32.65 M, Net Income -89.74 M, EPS -0.1449

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00459
0.121
+61.33%
+0.046
08186
0.475
+53.23%
+0.165
01545
0.124
+49.40%
+0.041
00339
0.207
+42.76%
+0.062
08400
0.048
+33.33%
+0.012
00254
0.600
+33.33%
+0.150
01146
0.042
+23.53%
+0.008
08613
0.058
+23.40%
+0.011
03889
0.100
+21.95%
+0.018
03302
0.425
+19.72%
+0.070
View More